Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding study of gemcabene in hypercholesterolemia on stable high-intensity statin therapy
2015-005756-10Phase 2Terminated
- Sponsor
- Gemphire Therapeutics
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypercholesterolemia comparing Gemcabene dose arm(s) with Placebo (2 arms). Primary endpoint: Percent change in LDL-C from baseline. Started Mar 2016; status: terminated.
02
Drugs
gemcabene
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on 2015-005756-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005756-10.